Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children

Tropical Medicine and International Health

Volumn 9, Issue 5, 2004, Pages 606-614

  Sowunmi, A ^a,b   Fehintola, F A ^a,b   Adedeji, A A ^a,b   Gbotosho, G O ^a,b   Falade, C O ^a,b   Tambo, E ^a,b   Fateye, B A ^a,b   Happi, T C ^a,b   Oduola, A M J ^a,b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Children; Malaria; Nigeria; Probenecid; Pyrimethamine sulphadoxine

Indexed keywords

FANSIDAR; PROBENECID;

CHILD HEALTH; DISEASE TREATMENT; DRUG RESISTANCE; MALARIA;

ABDOMINAL PAIN; ANOREXIA; ARTICLE; BLOOD TOXICITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DROWSINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING; WEIGHT GAIN;

ACUTE DISEASE; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGANIC ANION TRANSPORTERS; PARASITEMIA; PROBENECID; PYRIMETHAMINE; SULFADOXINE; TREATMENT OUTCOME;

AFRICA; NIGERIA; SUB-SAHARAN AFRICA; WEST AFRICA;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 2442661324     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2004.01233.x     Document Type: Article

References (39)

1. Anonymous (1994) Epi Info Version 6. A Word Processing Data Base and Statistics Program for Public Health on IBM-compatible Microcomputers. Centers for Disease Control and Prevention, Atlanta, GA.
2. Basco LK, Same-Ekobo A, Ngane V et al. (2002) Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulphadoxine-pyrimethamine- amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon. Bulletin of the World Health Organization 80, 538-545.
3. Borst P, Evers R, Kool M & Wijnbolds J (2000) A family of drug transporters:the multidrug resistance-associated proteins. Journal of National Cancer Institute 92, 1295-1302.
4. van Dillen J, Custers M, Wensink A et al. (1999) A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 185-188.
5. Diourté Y, Djimdé A, Doumbo OK et al. (1999) Pyrimethamine-sulphadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali. American Journal of Tropical Medicine and Hygiene 60, 475-478.
6. Drakeley CJ, Jawara M, Targett GAT et al. (2004) Addition of artesunate to chloroquine for the treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Tropical Medicine and International Health 9, 53-61.
7. Duraisingh MT, Drakeley CJ, Muller O et al. (1997) Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology 114, 205-211.
8. Ekanem OJ (1985) Plasmodium falciparum infection not responding to chloroquine. Transactions of the Royal Society of Tropical Medicine and Hygiene 79, 141-142.
9. Ekanem OJ, Weisfeld JS, Salako LA et al. (1987) Sensitivity of Plasmodium falciparum to chloroquine and sulphadoxine-pyrimethamine in Nigerian children. Bulletin of the World Health Organization 68, 45-52.
10. Falade CO, Salako LA, Sowunmi A, Oduola AMJ & Larcier P (1997) Comparative efficacy of chloroquine, halofantrine and sulphadoxine-pyrimethamine in treatment of acute uncomplicated falciparum malaria in Nigerian children. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 58-62.
11. Gasasira AF, Dorsey G, Nzarubara B et al. (2003) Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. American Journal of Tropical Medicine and Hygiene 68, 127-132.
12. Happi GT, Thomas SM, Gbotosho GO et al. (2003) Point mutations in the pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria. Annals of Tropical Medicine and Parasitology 97, 439-451.
13. Hooijberg JH, Broxterman HJ, Kool M et al. (1999) Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Research 59, 2532-2535.
14. Nzila A, Mberu E, Bray P et al. (2003) Chemosensitization of Plasmodium falciparum by probenecid in vitro. Antimicrobial Agents and Chemotherapy 47, 2108-2112.
15. Omar SA, Adagu IS, Gump DW, Ndaru NP & Warhurst DC (2001) Plasmodium falciparum in Kenya: high prevalence of drug-resistance-associated polymorphism in hospital admissions with severe malaria in an epidemic area. Annals of Tropical Medicine and Parasitology 95, 661-669.
16. Plowe CV, Cortese JF, Djimde A et al. (1997) Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthetase and the epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. Journal of Infectious Diseases 176, 1590-1596.
17. Price R, Nosten F, Simpson et al. (1999) Risk factors for gametocyre carriage in uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene 60, 1019-1023.
18. Robert V, Molez J-F & Trape J-F (1996) Short report: Gametocytes, chloroquine pressure, and the relative parasite survival advantage of resistant strains of falciparum malaria in West Africa. American Journal of Tropical Medicine and Hygiene 55, 350-351.
19. Robert V, Awono-Ambene HP, LeHesran J-Y & Trape J-F (2000) Gametocytaemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine-pyrimethamine. American Journal of Tropical Medicine and Hygiene 62, 210-216.
20. Salako LA & Aderounmu AF (1987) In vitro chloroquine and mefloquine-resistant Plasmodium falciparum in Nigeria. Lancet 1, 572-573.
21. Salako LA, Ajayi FO, Sowunmi A & Walker O (1990) Malaria in Nigeria: a revisit. Annals of Tropical Medicine and Parasitology 84, 435-445.
22. von Seidlein L, Milligan P, Pinder M et al. (2000) Efficacy of artesunate plus pyrimethamine-sulfadoxine for uncomplicated malaria in Gambian children. Lancet 355, 352-357.
23. von Seidlein L, Drakeley C, Greenwood B, Walraven G & Targett G (2001) Risk factors for gametocyte carriage in Gambian children. American Journal of Tropical Medicine and Hygiene 65, 523-526.
24. Sibley CH, Hyde JE, Sims et al. (2001) Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends in Parasitology 17, 582-588.
25. Sowunmi A (2002) A randomized comparison of chloroquine, amodiaquine and their combination with pyrimethamine-sulfadoxine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. Annals of Tropical Medicine and Parasitology 96, 227-238.
26. Sowunmi A (2003) A randomized comparison of chloroquine and chloroqunie plus ketotifen, in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. Annals of Tropical Medicine and Parasitology 97, 103-117.
27. Sowunmi A & Fateye BA (2003a) Asymptomatic, recrudescent, chloroquine-resistant Plasmodium falciparum infections in Nigerian children: clinical and parasitological characteristics and implications for transmission of drug-resistant infections. Annals of Tropical Medicine and Parasitology 97, 469-479.
28. Sowunmi A & Fateye BA (2003b) Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs. Tropical Medicine and International Health 8, 783-792.
29. Sowunmi A, Oduola AMJ, Salako LA et al. (1993) Intramuscular sulphadoxine-pyrimethamine in chloroquine-resistant Plasmodium falciparum malaria during pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene 84, 472.
30. Sowunmi A, Oduola AMJ, Ogundahunsi O et al. (1997) Enhanced efficacy of chloroquine/chlorpheniramine combination in acute uncomplicated falciparum malaria in children. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 63-67.
31. Sowunmi A, Oduola AMJ, Ogundahunsi OAT & Salako LA (1998a) Comparative efficacy of chloroquine plus chlorpheniramine and pyrimethamine-sulphadoxine in acute uncomplicated falciparum malaria in Nigerian children. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 77-81.
32. Sowunmi A, Oduola AMJ, Ogundahunsi OAT & Salako LA (1998b) Enhancement of the antimalarial effect of chloroquine by chlorpheniramine in vivo. Tropical Medicine and International Health 3, 177-183.
33. Sowunmi A, Fehintola FA, Ogundahunsi OAT & Oduola AMJ (1998c) Comparative efficacy of chloroquine plus chlorpheniramine and halofantrine in acute uncomplicated falciparum malaria in Nigerian children. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 441-445.
34. Sutherland CJ, Alloueche A, Curtis J et al. (2002) Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes. American Journal of Tropical Medicine and Hygiene 67, 575-585.
35. Trape JF (2001) The public health impact of chloroquine resistance in Africa. American Journal of Tropical Medicine and Hygiene 64 (Suppl 1-2), 12-17.
36. Trape J-F, Pison G, Preziosi M-P et al. (1998) Impact of chloroquine resistance on malaria mortality. Life Sciences 321, 689-697.
37. Wang P, Lee C-S, Bayoumi R et al. (1997) Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origin. Molecular and Biochemical Parasitology 89, 161-177.
38. World Health Organization (WHO) (1973) Chemotherapy of Malaria and Resistance to Antimalarials. WHO Technical Report Series No. 529, Geneva.
39. World Health Organization (2000) Severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 94 (Suppl. 1).